BQWNH - EPINEPHRINE INJECTION
- MSDS: BQWNH
- Manufacturer: FUJISAWA USA INC FUJISAWA PHARMACEUTICAL CO
- Product Name: EPINEPHRINE INJECTION
- National Stock Number: 6505-01-149-3559
Product Identification
Product ID:EPINEPHRINE INJECTION
MSDS Date:10/07/1992
FSC:6505
NIIN:01-149-3559
MSDS Number: BQWNH
Responsible Party
DEERFIELD, IL 60015-2548
US
Emergency Phone: 800-888-7704
Info Phone: 708-317-0800
Cage: 0K706
Contractor
Telephone: 708-317-0800 OR 800-888-7704
Cage: 0K706
Ingredients
EPINEPHRINE (SARA III)
CAS: 51-43-4
RTECS: DO2625000
Fraction By Weight: 0.01%
EPA Report Quantity: 1000 LBS
DOT Report Quantity: 1000 LBS
SODIUM CHLORIDE
CAS: 7647-14-5
RTECS: VZ4725000
Fraction By Weight: 0.816%
SODIUM METABISULFITE
CAS: 7681-57-4
RTECS: UX8225000
Fraction By Weight: 0.05%
OSHA PEL 5 MG/M3
ACGIH TLV: 5 MG/M3; 9293
WATER
CAS: 7732-18-5
RTECS: ZC0110000
PH ADJUSTED WITH CITIRIC ACID AND SODIUM CITRATE.
RTECS: 9999999ZZ
Hazards
LD50 LC50 Mixture:LD50 (ORAL, RAT) IS UNKNOWN.
Routes of Entry: Inhalation:NO Skin:NO Ingestion:NO
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:ACUTE- THIS PRODUCT IS INTENDED FOR
THERAPEUTIC USE ONLY WHEN PRESCRIBED BY A PHYSICIAN. POTENTIAL
ADVERSE REACTIONS FROM PRESCRIBED DOSES AND OVERDOSES ARE
PRESCRIBED IN THE PACKAGE INSERT. OCCUPATIO NAL EXPOSURE HAS NOT
BEEN FULLY INVESTIGATED. CHRONIC- NOT KNOWN
Effects of Overexposure:EYE, SKIN AND RESPIRATORY TRACT IRRITATION
Medical Cond Aggravated by Exposure:PRE-EXISTING SKIN DISORDERS MAY BE
MORE SUSCEPTIBLE TO THIS MATERIAL.
First Aid
First Aid:CONSULT PHYSICIAN IF SYMPTOMS PERSIST. EYE/SKIN:FLUSH WITH
WATER FOR 15 MINUTES. HOLD EYELIDS OPEN. INHALATION:REMOVE TO FRESH
AIR. PROVIDE CPR/OXYGEN IF NEEDED. INGESTION:FLUSH MOUTH OUT WITH
WATER I MMEDIATELY. SEEK MEDICAL ATTENTION.
Fire Fighting
Flash Point Method:CC
Flash Point:>200F,>93C
Extinguishing Media:WATER FOG, CARBON DIOXIDE, FOAM OR DRY CHEMICAL.
WATER SPRAY MAY BE USED TO KEEP FIRE EXPOSED CONTAINERS COOL.
Fire Fighting Procedures:WEAR PROTECTIVE CLOTHING AND NIOSH-APPROVED
SELF-CONTAINED BREATHING APPARATUS.
Unusual Fire/Explosion Hazard:MAY EMIT TOXIC FUMES OF NOX.
Accidental Release
Spill Release Procedures:WEAR PROTECTIVE EQUIPMENT. USE ABSORBENT
TOWELS OR BOOMS TO CLEAN-UP SPILL. WIPE SURFACES CLEAN AND WASH
WITH SOAP AND WATER.
Neutralizing Agent:WEAK BASE
Handling
Handling and Storage Precautions:AS A GENERAL RULE, WHEN HANDLING
PHARMACEUTICAL PRODUCTS, AVOID ALL CONTACT AND INHALATION OF DUST,
FUME, MISTS AND/OR VAPORS ASSOCIATED WITH PRODUCT.
Other Precautions:KEEP OUT OF REACH OF CHILDREN.
Exposure Controls
Respiratory Protection:WITH SATISFACTORY VENTILATION, RESPIRATORY
PROTECTION NOT USUALLY REQUIRED.
Ventilation:MECHANICAL (GENERAL) ROOM VENTILATION IS USUALLY
SATISFACTORY. USE LOCAL EXHAUST VENTILATION WHEN NECESSARY.
Protective Gloves:DISPOSABLE LATEX RECOMMENDED
Eye Protection:SAFETY GOGGLES/GLASSES RECOMMENDED
Other Protective Equipment:EYE WASH STATION, DISPOSABLE GARMENTS IF
DIRECT CONTACT IS ANTICIPATED.
Work Hygienic Practices:PRACTICE GOOD HYGIENIC PROCEDURE.
Supplemental Safety and Health
FLASH POINT IS ESTIMATED.
Chemical Properties
HCC:C3
Boiling Pt:B.P. Text:NOT KNOWN
Melt/Freeze Pt:M.P/F.P Text:NOT KNOWN
Vapor Pres:NOT KNOWN
Vapor Density:6.31
Spec Gravity:NOT KNOWN
pH:2.2-5
Evaporation Rate & Reference:NOT KNOWN
Solubility in Water:SLIGHTLY SOLUBLE
Appearance and Odor:CLEAR, COLORLESS, ODORLESS SOLUTION
Stability
Stability Indicator/Materials to Avoid:YES
STRONG BASES
Stability Condition to Avoid:EXPOSURE TO LIGHT MAY CAUSE DECOMPOSITION.
Hazardous Decomposition Products:MAY EMIT TOXIC FUMES OF NOX.
Disposal
Waste Disposal Methods:DISPOSE OF IN ACCORDANCE WITH ALL LOCAL, STATE
AND FEDERAL REGULATIONS.
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.